Faculty Collaboration Database

Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available? AIDS Behav 2018 Apr;22(4):1184-1189

Date

09/16/2017

Pubmed ID

28913659

Pubmed Central ID

PMC5851796

DOI

10.1007/s10461-017-1907-2

Scopus ID

2-s2.0-85029541366 (requires institutional sign-in at Scopus site)   50 Citations

Abstract

Oral pre-exposure prophylaxis (PrEP) is highly effective at reducing HIV transmission risk and is CDC recommended for many gay, bisexual, and other men who have sex with men (GBM). We sought to investigate awareness of and preference for using long-acting injectable PrEP (LAI-PrEP) among GBM currently taking oral PrEP (n = 104), and identify their concerns. About half of GBM had heard of LAI-PrEP, and 30.8% specifically preferred LAI-PrEP. GBM with more concerns about the level of protection and drug half-life of LAI-PrEP had lower odds of preferring LAI-PrEP. Given that daily pill adherence is a challenge for some on PrEP, it is important to investigate the degree to which those on PrEP might consider LAI-PrEP as an alternative.

Author List

John SA, Whitfield THF, Rendina HJ, Parsons JT, Grov C

Author

Steven A. John PhD Associate Professor in the Psychiatry and Behavioral Medicine department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Administration, Oral
Adolescent
Anti-HIV Agents
Bisexuality
HIV Infections
Health Knowledge, Attitudes, Practice
Homosexuality, Male
Humans
Injections
Male
Patient Acceptance of Health Care
Patient Preference
Pre-Exposure Prophylaxis
Surveys and Questionnaires
Young Adult